Stronger Together: Multivalent Phage Capsids Inhibit Virus Entry
- 27 August 2020
- journal article
- editorial
- Published by Wiley in ChemBioChem
- Vol. 22 (3) , 478-480
Abstract
Antivirals are now more important than ever. To efficiently inhibit virus replication, antiviral multivalent strategies need sufficient affinity to overcome the excellent matching between the virus and its receptor. This report highlights a phage capsid scaffold strategy that can be used to precisely position sialic acid moieties to inhibit influenza A virus replication.Keywords
Funding Information
- Xunta de Galicia (ED431C 2017/25)
- Instituto de Salud Carlos III (COV20/00297)
This publication has 17 references indexed in Scilit:
- Glycopeptides and -Mimetics to Detect, Monitor and Inhibit Bacterial and Viral Infections: Recent Advances and PerspectivesMolecules, 2019
- Carbohydrate–protein interactions and multivalency: implications for the inhibition of influenza A virus infectionsExpert Opinion on Drug Discovery, 2019
- InfluenzaNature Reviews Disease Primers, 2018
- Multivalent Glycosylated Nanostructures To Inhibit Ebola Virus InfectionJournal of the American Chemical Society, 2017
- Pathogen Inhibition by Multivalent Ligand ArchitecturesJournal of the American Chemical Society, 2016
- Synthesis of giant globular multivalent glycofullerenes as potent inhibitors in a model of Ebola virus infectionNature Chemistry, 2015
- A multivalent inhibitor of the DC-SIGN dependent uptake of HIV-1 and Dengue virusBiomaterials, 2014
- Multivalent dendrimeric compounds containing carbohydrates expressed on immune cells inhibit infection by primary isolates of HIV-1Virology, 2010
- Polyvalent Interactions in Biological Systems: Implications for Design and Use of Multivalent Ligands and InhibitorsAngewandte Chemie International Edition, 1998
- Polyvalente Wechselwirkungen in biologischen Systemen: Auswirkungen auf das Design und die Verwendung multivalenter Liganden und InhibitorenAngewandte Chemie, 1998